精氨酸加压素、和肽素与心力衰竭关系的研究进展

被引:34
作者
王全珍
陈焕芹
机构
[1] 山东大学齐鲁医院干部保健科
关键词
精氨酸加压素; 和肽素; 心力衰竭;
D O I
暂无
中图分类号
R541.6 [血液循环衰竭];
学科分类号
100201 [内科学];
摘要
<正>心力衰竭是由于各种原因的初始心肌损伤导致肾素-血管紧张素-醛固酮系统(RAAS)和交感神经系统兴奋性增高,各种神经内分泌介质又促进心肌重构,加重心肌损伤和心功能恶化,形成恶性循环。精氨酸加压素(AVP)就是这些神经内分泌
引用
收藏
页码:855 / 858
页数:4
相关论文
共 8 条
[1]
Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm [J].
Miller, Wayne L. ;
Hartman, Karen A. ;
Hodge, David O. ;
Hartman, Stacy ;
Struck, Joachim ;
Morgenthaler, Nils G. ;
Bergmann, Andreas ;
Jaffe, Allan S. .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (04) :526-535
[2]
C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial Infarction [J].
Kelly, Dominic ;
Squire, Iain B. ;
Khan, Sohail Q. ;
Quinn, Paulene ;
Struck, Joachin ;
Morgenthaler, Nils G. ;
Davies, Joan E. ;
Ng, Leong L. .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) :739-745
[3]
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal Pro-B-type natriuretic peptide in patients with chronic heart failure [J].
Neuhold, Stephanie ;
Huelsmann, Martin ;
Strunk, Guido ;
Stoiser, Brigitte ;
Struck, Joachim ;
Morgenthaler, Nils G. ;
Bergmann, Andreas ;
Moertl, Deddo ;
Berger, Rudolf ;
Pacher, Richard .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (04) :266-272
[4]
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study [J].
Khan, Sohail Q. ;
Dhillon, Onkar S. ;
O'Brien, Russell J. ;
Struck, Joachim ;
Quinn, Paulene A. ;
Morgenthaler, Nils G. ;
Squire, Iain B. ;
Davies, Joan E. ;
Bergmann, Andreas ;
Ng, Leong L. .
CIRCULATION, 2007, 115 (16) :2103-2110
[5]
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure [J].
Stoiser, B. ;
Moertl, D. ;
Huelsmann, M. ;
Berger, R. ;
Struck, J. ;
Morgenthaler, N. G. ;
Bergmann, A. ;
Pacher, R. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (11) :771-778
[6]
The role of arginine vasopressin in diabetes-associated increase in glucagon secretion [J].
Yibchok-anun, S ;
Abu-Basha, EA ;
Yao, CY ;
Panichkriangkrai, W ;
Hsu, WH .
REGULATORY PEPTIDES, 2004, 122 (03) :157-162
[7]
Vasopressin: A new target for the treatment of heart failure [J].
Lee, CR ;
Watkins, ML ;
Patterson, JH ;
Gattis, W ;
O'Connor, CM ;
Gheorghiade, M ;
Adams, KF .
AMERICAN HEART JOURNAL, 2003, 146 (01) :9-18
[8]
Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy.[J].Rong Tian;Nicolas Musi;Jessica D’Agostino;Michael F. Hirshman;Laurie J. Goodyear.Circulation: Journal of the American Heart Association.2001, 14